Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
12 Dec 2014

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
12 Dec 2014

Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma

Dr Peter Vandenberghe - Universitair Ziekenhuis Leuven, Leuven, Belgium
Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma ( Dr Peter Vandenberghe - Universitair Ziekenhuis Leuven, Leuven, Belgium )
12 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014

Oprozomib shows potential in the treatment of multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA
Oprozomib shows potential in the treatment of multiple myeloma ( Dr Ravi Vij - Washington University School of Medicine, St Louis, USA )
8 Dec 2014

Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma

Dr Ravi Vij - Washington University School of Medicine, St Louis, USA
Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma ( Dr Ravi Vij - Washington University School of Medicine, St Louis, USA )
8 Dec 2014

Combination therapy for high-risk MDS? Not quite yet

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Combination therapy for high-risk MDS? Not quite yet ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )
8 Dec 2014

Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma

Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014

ASH 2014: Highlights in mantle cell lymphoma

Prof Steven Le Gouill and Prof Simon Rule
ASH 2014: Highlights in mantle cell lymphoma ( Prof Steven Le Gouill and Prof Simon Rule )
8 Dec 2014

ASH 2014: Highlights in multiple myeloma

Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios Dimopoulos
ASH 2014: Highlights in multiple myeloma ( Prof Philippe Moreau, Prof Keith Stewart, Prof Marivi Mateos, Prof Meletios Dimopoulos )
8 Dec 2014